Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER⁺ Breast Cancer

Míreanna comhchosúla

• Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
  de réir: Biagio Ricciuti (14951247)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
  de réir: Arathi Mohan (15561346)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
  de réir: Arathi Mohan (15561346)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
  de réir: Tom Wei-Wu Chen (15053003)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
  de réir: Tom Wei-Wu Chen (15053003)
  Foilsithe / Cruthaithe: (2025)